This inventor holds 1 USPTO granted patent. Top assignee: Genuone Sciences Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Chae Shin Seo: Innovator in Pharmaceutical Composition for Inflammatory Bowel Disease
Introduction: Chae Shin Seo, a distinguished inventor based in Daegu, South Korea, has made significant strides in the field of pharmaceuticals. His research focuses on developing innovative compositions aimed at preventing and treating inflammatory bowel disease (IBD). With one patent to his name, he has contributed to medical advancements that may enhance the quality of life for individuals suffering from IBD.
Latest Patents: Chae Shin Seo's patent concerns a pharmaceutical composition that comprises a mixed extract of at least two of Decne, Retzius, and Rosc as an active ingredient. This composition has been shown to effectively inhibit monocyte adhesion in intestinal epithelial cells and reduce the production of inflammatory cytokines. Furthermore, it has demonstrated efficacy in ameliorating colitis in animal models of dextran sodium sulfate (DSS)-induced colitis and improving conditions related to Crohn's disease in models induced by 2,4,6-trinitrobenzenesulfonic acid (TNBS).
Career Highlights: Currently, Chae Shin Seo is affiliated with Genuone Sciences Inc., where he continues to advance his research. His work is crucial in paving the way for new therapeutic methods that address inflammatory conditions affecting the gastrointestinal tract.
Collaborations: Throughout his career, Chae Shin Seo has collaborated with fellow researchers such as Yong-baik Cho and Seul-ki Kim. Their collective expertise and research efforts in pharmaceutical sciences contribute to the development of innovative treatments aimed at improving health outcomes for patients.
Conclusion: Chae Shin Seo represents the spirit of innovation in the pharmaceutical industry. His dedication to addressing significant health challenges, such as inflammatory bowel disease, showcases the importance of inventive thinking in medicine. As he continues to work with Genuone Sciences Inc. and his colleagues, the potential impact of his inventions may play a pivotal role in the future of therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile